By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Vitamin K antagonist > Warfarin

Warfarin

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|621 words

Warfarin Drug Profile

What is Warfarin?

Warfarin is an oral anticoagulant medication belonging to the vitamin K antagonist class of drugs. It is widely prescribed to prevent and treat blood clots by reducing the blood’s ability to form clots. Warfarin has been used for over 70 years and remains one of the most commonly prescribed anticoagulants worldwide.

Uses

Warfarin is prescribed for several conditions involving blood clot prevention and treatment:

  • Atrial fibrillation: Prevents stroke by reducing clot formation in patients with irregular heart rhythms
  • Deep vein thrombosis (DVT): Treats and prevents blood clots in the deep veins, typically in the legs
  • Pulmonary embolism: Prevents and treats life-threatening blood clots that travel to the lungs
  • Heart valve replacement: Prevents clots in patients with mechanical heart valves
  • Post-surgical prevention: Reduces clot risk after certain surgeries, particularly hip or knee replacement

How it works

Warfarin works by blocking the action of vitamin K in the liver, which is essential for producing several clotting factors in the blood. By interfering with this process, warfarin reduces the liver’s ability to make proteins necessary for blood clotting, effectively “thinning” the blood. This mechanism makes it take longer for blood to clot, reducing the risk of harmful clot formation while maintaining the body’s ability to stop bleeding when injured.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Easy bruising
  • Minor bleeding (nosebleeds, gum bleeding)
  • Skin rash
  • Hair loss
  • Nausea
  • Diarrhea
  • Abdominal pain
  • Fatigue

Serious side effects requiring immediate medical attention:

  • Major bleeding (internal bleeding, severe nosebleeds)
  • Signs of stroke (sudden weakness, speech problems, vision changes)
  • Purple toe syndrome (rare condition causing toe discoloration and pain)
  • Skin necrosis (tissue death, usually within first few days of treatment)
  • Severe allergic reactions

Warnings and precautions

  • Pregnancy: Warfarin is contraindicated during pregnancy as it can cause birth defects and bleeding complications. Women of childbearing age should use effective contraception.
  • Bleeding disorders: Patients with active bleeding, bleeding disorders, or recent surgery should generally avoid warfarin or use it with extreme caution.
  • Liver disease: Patients with severe liver impairment may have increased sensitivity to warfarin and require dose adjustments and closer monitoring.
  • Fall risk: Elderly patients or those at high risk of falls need careful evaluation, as injuries could lead to serious bleeding complications.
  • Regular monitoring required: Patients must have regular blood tests (INR) to ensure proper dosing and prevent complications.

Interactions

Warfarin has numerous drug and supplement interactions that can either increase bleeding risk or reduce effectiveness:

  • Antibiotics (especially fluoroquinolones, macrolides): Can increase warfarin effects and bleeding risk
  • NSAIDs (ibuprofen, naproxen): Increase bleeding risk when combined with warfarin
  • Aspirin: Significantly increases bleeding risk and requires careful monitoring if used together
  • Vitamin K supplements and foods: Can reduce warfarin effectiveness by counteracting its mechanism
  • St. John’s Wort: May decrease warfarin effectiveness, increasing clot risk
  • Cranberry products: May increase warfarin effects and bleeding risk
  • Alcohol: Can either increase or decrease warfarin effects depending on consumption patterns
  • Antifungal medications: Many can significantly increase warfarin effects

Check interactions with the GMJ Interaction Checker

Dosage

Warfarin dosing is highly individualized and typically starts at 2.5-10 mg daily for most adults, with elderly patients often starting at lower doses. The maintenance dose usually ranges from 1-15 mg daily, depending on the patient’s response measured by INR (International Normalized Ratio) blood tests. Dosage adjustments are made based on regular INR monitoring, with target INR ranges typically between 2.0-3.0 for most conditions, or 2.5-3.5 for patients with mechanical heart valves. All dosing decisions must be made by a healthcare provider based on individual patient factors and regular laboratory monitoring.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Warfarin." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/warfarin/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Related topics

Optional further reading from the GMJ knowledge base.

In the news
Evidence review: Which supplements older adults actually need and which ones to avoid
In the news
  • Evidence review: Which supplements older adults actually need and which ones to avoid · Jun 12, 2026
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Eggs and Alzheimer’s risk: New evidence from a 15-year study challenges decades of dietary caution

A 15-year study of 39,498 older adults found that eating eggs five…

Sleep loss triggers simultaneous damage across seven body systems, new evidence shows

Controlled studies show that restricting sleep to 4–6 hours per night for…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Acenocoumarol

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up